Chief of Staff
Maisha MedsMaisha Meds is looking for a Chief of Staff to join our team in May 2021. They’ll be responsible for supporting the executive team on communications, the people function, and strategic initiatives.
This role is based in Nairobi, Kenya, with potential travel to Kisumu. You will report directly to the CEO for this role, and provide indirect supervision of various team members based on the active portfolio.
We are looking for an enthusiastic strategic thinker and strong communicator to support the executive team on driving results and shaping organisational culture. The Chief of Staff will be an essential part of a leadership team that is working to build a fun yet strongly performance-based culture at Maisha Meds and help us build out systems and processes for scale. You will do a mix of internal and external relationship management, spearhead key initiatives, and help shape Maisha Meds into a company with a focus on impact and sustainability while also maintaining our nimble approach to problem-solving and testing new solutions.
Maisha Meds reserves the right to adapt the work scope for the employee, in response to company needs or changes in direction.
Maisha Meds aims to leverage technology to solve problems that affect millions of people across sub-Saharan Africa. We can promise you an opportunity to drive real, quantifiable change that literally saves lives. We are dedicated to our work and care deeply about our product’s impact. You’ll join our small and friendly team to grow Maisha Meds into a company serving tens of millions of people across East Africa.
Start date is early May, and compensation is commensurate with experience.
About Maisha Meds
Maisha Meds is an organisation dedicated to improving health care in Africa. We began full-time operations in 2017 and over the past few years has grown to support over 4 million patient encounters at over 1,200 pharmacies and drug shops annually across Kenya, Tanzania, Uganda, Nigeria, and Zambia. We are building the financial and technology infrastructure to enable global health funders to pay for health outcomes at the last mile, with an initial focus on malaria case management. Recent results from a randomised controlled trial with UC Berkeley showed that our programs lead to a statistically significant 350% increase in appropriate and high quality malaria care. Based on these results, we are planning to scale the technology to reach over 10,000 health facilities and 20 million patients, and to directly pay for health outcomes for 1 million patients annually by 2024. In addition, we are actively building programs to support injectable contraceptives, HIV pre-exposure prophylaxis, measles and HPV vaccines, malnutrition support, and safe water interventions.
Our work is funded by USAID Development Innovation Ventures, the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, Grand Challenges Canada, Pfizer, and others, and we are starting to build partnerships with multilateral global health funders, pharmaceutical companies, and national health insurance funds to have them pay us on a contract basis for health outcomes. We use data from our point of sale software to design programs that leverage financial incentives to improve uptake of high impact health products. And we measure our success by our ability to improve the quality and affordability of healthcare diagnosis, treatment, and prevention for low-income patients across Africa.